Loading...
SPE2DP-26-R-0001
Response Deadline
May 29, 2026, 3:59 AM(EDT)17 days
Eligibility
Contract Type
Presolicitation
Japanese Encephalitis Virus Vaccine, Purified, Inactivated, Single-Dose Prefilled Syringe (JEV) - Synopsis
Solicitation: SPE2DP-26-R-0001
Item: Japanese Encephalitis Virus Vaccine, Purified, Inactivated, Single-Dose Prefilled Syringe (JEV)
NSN: 6505-01-607-7018
Description:
The Defense Logistics Agency Troop Support has a requirement for the supply of Japanese Encephalitis Virus Vaccine, Purified, Inactivated, Single-Dose Prefilled Syringe (JEV). JEV shall be made in accordance with MPID Number 5 dated 23 July 2024, which is attached to this notice.
The Solicitation will be issued under authority 10 U.S.C. § 3204(a)(1), implemented by FAR 6.302-1 (“Only one responsible source and no other supplies or services will satisfy agency requirements”).
The Government intends to use Part 12 for this acquisition – per FAR 10.002(d)(2).
The proposed contract will be a firm-fixed price, indefinite delivery, indefinite quantity type contract. The contract will consist of an eighteen (18) month base term. The minimum quantity is 277,760 each (EA). The estimated quantity is 277,760 each. The maximum quantity is 394,240 each.
Inspection/Acceptance at Destination
FOB Destination
Delivery Destination:
DODAAC: SV3100
DLA Distribution Susquehanna
U Avenue, Bldg. 89, Door 6
New Cumberland, PA 17070
Attn: Jim Earp
Production Lead Time is 120 days after issuance date of the delivery order (DD1155).
All responsible sources may submit a proposal and shall be considered by the Agency.
The successful contractor shall have FDA approval to sell JEV prior to the Solicitation’s closing date and time.
****************************************************************************
IMPORTANT NOTICES
Availability of solicitations, FAR 5.102(d) applies, as our office no longer issues solicitations or amendments in paper form. Offeror should register to receive notification of this solicitation or solicitation amendments. The solicitation will be posted on the DLA Internet Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil/. Detailed system requirements and instructions for registration can be found on the DLA DIBBS Home Page accessed on https://www.dibbs.bsm.dla.mil/. Once the solicitation is posted, it will be available for viewing on DIBBS. From the DIBBS homepage, select "Solicitations" from the top bar to search for the solicitation. DIBBS Help can be accessed from the DIBBS homepage. Interested parties are further advised to set up automated notifications of solicitation changes through this website. Solicitation SPE2DP-23-R-0002 is expected to be issued on or around May 2024.
******************************************************************************
Contracting Office Address:
Defense Logistics Agency, Acquisition Management, DLA Troop Support - Medical, 700 Robbins Avenue, Philadelphia, PA, 19111-5092, UNITED STATES
Point of Contact(s):
Alec Deichman, Contracting Specialist, Phone: 445-737-5743 , Email: Alec.Deichman@dla.mil
Jessica De La Hoz, Contracting Officer, Phone: 445-737-3623, Email: Jessica.DeLaHoz@dla.mil
DEPT OF DEFENSE
DEFENSE LOGISTICS AGENCY
TROOP SUPPORT MEDICAL
DLA TROOP SUPPORT
DLA TROOP SUPPORT
MEDICAL SUPPLY CHAIN PHARM FSA
700 ROBBINS AVENUE
PHILADELPHIA, PA, 19111
NAICS
Biological Product (except Diagnostic) Manufacturing
PSC
DRUGS AND BIOLOGICALS
Set-Aside
No Set aside used